Sundanese
English French German Portuguese Spanish Russian Japanese Korean Arabic Irish Greek Turkish Italian Danish Romanian Indonesian Czech Afrikaans Swedish Polish Basque Catalan Esperanto Hindi Lao Albanian Amharic Armenian Azerbaijani Belarusian Bengali Bosnian Bulgarian Cebuano Chichewa Corsican Croatian Dutch Estonian Filipino Finnish Frisian Galician Georgian Gujarati Haitian Hausa Hawaiian Hebrew Hmong Hungarian Icelandic Igbo Javanese Kannada Kazakh Khmer Kurdish Kyrgyz Latin Latvian Lithuanian Luxembou.. Macedonian Malagasy Malay Malayalam Maltese Maori Marathi Mongolian Burmese Nepali Norwegian Pashto Persian Punjabi Serbian Sesotho Sinhala Slovak Slovenian Somali Samoan Scots Gaelic Shona Sindhi Sundanese Swahili Tajik Tamil Telugu Thai Ukrainian Urdu Uzbek Vietnamese Welsh Xhosa Yiddish Yoruba Zulu Kinyarwanda Tatar Oriya Turkmen Uyghur
Leave Your Message

Submit An Free Inquiry

Our medical team will make an evaluation for you, based on the information you provided. This procedure is free of charge.

AI Helps Write
AI Helps Write

Wang Liang

Judul：Dokter Kapala
Jabatan: Kapala Divisi
Profil Pribadi：Dokter Kapala, Profesor, Ph.D. Pembimbing, ayeuna Direktur Departemen Hematologi Rumah Sakit Peking Tongren. Anjeunna lulus ti Peking Union Medical College dina taun 2010, jurusan Kedokteran Klinis dina sistem dalapan taun, sareng kéngingkeun gelar Doktor Kedokteran. Anjeunna parantos kalibet dina diagnosis sareng pangobatan tumor hematologis (limfoma, multiple myeloma, jsb.) salami langkung ti 10 taun, sareng gaduh pangalaman klinis anu beunghar sareng prestasi akademik anu luhur dina diagnosis sareng pangobatan rupa-rupa jinis limfoma sareng myeloma, sareng spesialisasi dina imunoterapi anu ditargetkeun, kemoterapi, terapi sél CAR-T, transplantasi sél stém hematopoietik, sareng mingpin pamekaran diagnosis sareng pangobatan multidisiplin (MDT). Minat panalungtikan utama anjeunna nyaéta imunoterapi anu ditargetkeun sareng éksplorasi mékanisme résistansi ubar limfoma, sareng anjeunna parantos mingpin sababaraha Yayasan Élmu Alam Nasional Cina. Anjeunna parantos nerbitkeun langkung ti 40 makalah profésional, kalebet langkung ti 30 makalah anu diindeks SCI, anu parantos diterbitkeun dina Lancet Haematology, Journal of Hematology & Oncology, Leukemia, Clinical Cancer Research, Cancer Treatment Reviews, Cancer Therapy Reviews, sareng jurnal sareng jurnal sanésna. Anjeunna parantos nerbitkeun dina Lancet Haematology, Journal of Hematology & Oncology, Leukemia, Clinical Cancer Research, Cancer Treatment Reviews, Cancer, British Journal of Cancer, Annals of Hematology, sareng Leukemia & Lymphoma. Anjeunna mangrupikeun ko-éditor Standard Leukemia Diagnosis and Treatment, Standard Multiple Myeloma Diagnosis and Treatment, sareng Medical Oncology. Anjeunna dileler "Respect for Life-2017 Glory to Healers-Youth Innovation Award", "Tongren Elite" panghargaan dina taun 2020, "Tongren Hospital Outstanding Young Talent" panghargaan dina taun 2020, sareng panghargaan "Tongren Hospital Outstanding Young Talent" anu munggaran dina taun 2020. Tongren Hospital Outstanding Young Talent" dina taun 2020, '35 Ahli Onkologi Ngora Di Bawah 35 Taun Anu Panglobana Poténsina di Cina'. Afiliasi Akademik: Anggota Ngora Cabang Hematologi Asosiasi Médis Cina; Anggota Tetep Komite Imunoterapi Limfoma Masyarakat Pencegahan sareng Kontrol Kanker Beijing; Anggota Tetep Komite Myeloma Asosiasi Pendidikan Médis Cina; Ahli Yayasan Élmu Alam Nasional Cina. Anjeunna mangrupikeun éditor asosiasi Aging Pathobiology and Therapeutics, anggota dewan éditor Chinese Journal of Cancer Prevention and Control, anggota dewan éditor ngora Concord Medical Journal, sareng reviewer Journal of Hematology & Oncology sareng Cancer Biology & Medicine.

Wang Liang